Quote Lookup

Please enter a ticker symbol below and click Submit.
Symbol:        VL Survey Page (2014-03-14)Premium Content

Isis Pharmaceuticals Inc (ISIS)

2014-04-15@17:54:05 ET
Isis Pharmaceuticals Has Returned 34.1% Since SmarTrend Recommendation (ISIS) (PSM)

2014-04-15@14:23:59 ET
Isis Pharmaceuticals (ISIS) Trading Near $30.87 Support Level (FBM)

2014-04-15@13:14:58 ET
Isis Pharmaceuticals Makes a Move: Down 4.9% (F77)

2014-04-14@18:04:25 ET
SmarTrend Watching for Potential Rebound in Shares of Isis Pharmaceuticals After 2.12% Loss (PSM)

2014-04-14@13:42:26 ET
Research and Markets: Global RNAi Drug Delivery Market 2014-2018 with Alnylam Pharmaceuticals, Isis Pharmaceuticals.,Merck & Co & Tekmira Pharmaceuticals Dominating (BIZ)

2014-04-14@12:27:42 ET
Global RNAi Drug Delivery Market 2014-2018 with Alnylam Pharmaceuticals, Isis Pharmaceuticals.,Merck & Co & Tekmira Pharmaceuticals Dominating (MTO)

2014-04-14@10:30:56 ET
Isis Pharmaceuticals (ISIS) Trading Near $38.77 Resistance Level (FBM)

2014-04-11@16:26:56 ET
Isis Pharmaceuticals (ISIS) Trading Near $32.23 Support Level (FBM)

2014-04-10@15:04:47 ET
Isis Pharmaceuticals (ISIS) Showing Support Near $35.77 (FBM)

2014-04-10@08:01:19 ET
Top 5 Companies in the Biotechnology Industry with the Best Relative Performance (CYTK, CLDX, ISIS, ALKS, VRTX) (F70)

2014-04-10@05:47:05 ET
Isis reports encouraging results from Phase II high triglyceride study (DTM)

2014-04-09@16:39:11 ET
Isis Pharmaceuticals (ISIS) Showing Bearish Technicals With Support At $34.82 (FBM)

2014-04-04@15:46:03 ET
Isis Pharmaceuticals (ISIS) Showing Bearish Technicals (FBM)

2014-04-04@13:09:07 ET
Isis Pharmaceuticals Shares Sinking Lower, Down 7.1% (F77)

2014-04-04@08:19:59 ET
Form 4: Update Filing for ISIS Pharmaceuticals Inc (ISIS) (VKR)

2014-04-04@08:16:05 ET
Short-term Underperformance Detected in Shares of Exact Sciences in the Biotechnology Industry (EXAS, CLDX, IDIX, NPSP, ISIS) (F70)

2014-04-03@18:08:22 ET
After Yesterday's Decline of 6.41%, Isis Pharmaceuticals Offers Investors Better Value (PSM)